Abstract
The first heart transplantation was carried out in Japan successfully, after the brain death and organ transplantation law was settled in 1997. The recipient patient was a 47-year-old man with the dilated phase of hypertrophic cardiomyopathy who had been on a Novacor implantable left ventricular assist system for the previous 4 months. Since the donor hospital was about 200 km from the recipient hospital which took approximately 2 hours for transportation, the total ischemic time was 3 hours and 24 minutes. The post-transplant course was smooth, and the patient was discharged on postoperative day 75.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ. The registry of the international society for heart and lung transplantation: 15th official report—1998. J Heart Lung Transplant 1998; 17: 656–68.
Wang SS, Chu SH. Current status of heart assist and replacement in Taiwan. Artif Organs. 1996; 20: 1325–9.
Oyer PE, Stinson EB, Jamieson SW, Reitz BA, Hunt SA, Wallwork J, et al. Cyclosporine in cardiac transplantation: a 2 1/2 year follow-up. Transplant Proc 1983; 15: 2546–52.
Pennington DG. Extended support with permanent systems: percutaneous versus totally implantable. Ann Thorac Surg 1996; 61: 403–7.
DeRose JJ Jr, Umana JP, Argenziano M, Catanese KA, Gardocki MT, Flannery-M, et al. Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery. J Am Coll Cardiol 1997; 30: 1773–7.
Matsuda H, Kaneko M, Masai T, Matsuwaka R, Miyamoto Y, Sakakibara T. A successful use of VAS for bridge to heart transplantation after oversea transportation in a 18-year-old patient with dilated cardiomyopathy. (in Japanese with English abstract) J Jpn Assn Thorac Surg 1994; 42: 1984–9.
Sawa Y, Taniguchi K, Kadoba K, Nishimura M, Ichikawa H, Amemiya A, et al. Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy. Circulation 1996; 93: 1640–6.
Fukushima N, Shirakura R, Nakata S, Kaneko M, Miyagawa S, Naka Y, et al. Study of efficacies of leukocyte-depleted terminal blood cardioplegia in 24-hour preserved hearts. Ann Thorac Surg 1994; 58: 651–6.
White M, Pelletier GB, Tan A, Jesina C, Carrier-M. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients. J Heart Lung Transplant 1997; 16: 787–94.
Kobashigawa J, Miller L, Renlund D, Mentzer R, Alderman E, Bourge R, et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. mycophenolate mofetil investigators. Transplantation 1998; 66: 507–15.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsuda, H., Fukushima, N., Sawa, Y. et al. First brain dead donor heart transplantation under new legislation in Japan. Jpn J Thorac Caridovasc Surg 47, 499–505 (1999). https://doi.org/10.1007/BF03218050
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03218050